Insider Trading: AcelRx Pharmaceuticals Inc (ACRX.O)

ACRX.O on Consolidated Issue listed on NASDAQ Global Market

9.60USD
18 Jun 2013
Price Change (% chg)

$-0.32 (-3.23%)
Prev Close
$9.92
Open
$10.00
Day's High
$10.13
Day's Low
$9.40
Volume
353,339
Avg. Vol
433,029
52-wk High
$10.59
52-wk Low
$2.27

Search Stocks
WAN MARK A Options Exercised: 0
Trade Date: Monday, 28 May 2012 Price: 3.40
Title: Director and Beneficial Owner Shares Held: 7,950,123
Type Traded: Indirect Net Change in Shares This Filing: 284,698

Institutional Holders

% Shares Owned: 80.48%
# of Holders: 46
Total Shares Held: 29,969,592
3 Mo. Net Change: -1,259,195
# New Positions: 13
# Closed Positions: 9
# Increased Positions: 25
# Reduced Positions: 16
# Net Buyers: 9

Officers & Directors

Name Age Since Current Position

Adrian Adams

62 2013 Independent Chairman of the Board

Richard King

48 2010 President, Chief Executive Officer, Director

James Welch

55 2010 Chief Financial Officer

Pamela Palmer

50 2005 Chief Medical Officer, Director

Badri Dasu

49 2007 Chief Engineering Officer

Lawrence Hamel

61 2006 Chief Development Officer

Mark Edwards

55 2011 Independent Director

Stephen Hoffman

58 2010 Independent Director

Guy Nohra

52 2006 Independent Director

Howard Rosen

54 2008 Independent Director

Mark Wan

47 2006 Independent Director
Search Stocks